Covered recipient · General Payments record
THOMAS S BEMIS
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$721.87
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.17 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $106.76 | 4 |
| Gilead Sciences, Inc. | $53.96 | 2 |
| SpringWorks Therapeutics, Inc. | $36.65 | 1 |
| Alexion Pharmaceuticals, Inc. | $34.64 | 1 |
| Mirati Therapeutics, Inc. | $25.93 | 1 |
| Genentech USA, Inc. | $24.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $34.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093993688 | CMS |
| Genentech USA, Inc. | $24.23 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133125033 | CMS |
| Gilead Sciences, Inc. | $24.04 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133795123 | CMS |
| Gilead Sciences, Inc. | $29.92 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133795125 | CMS |
| Lilly USA, LLC | $31.33 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464410 | CMS |
| Lilly USA, LLC | $20.28 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135495174 | CMS |
| Lilly USA, LLC | $26.29 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135465492 | CMS |
| Lilly USA, LLC | $28.86 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135438256 | CMS |
| Mirati Therapeutics, Inc. | $25.93 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117175504 | CMS |
| SpringWorks Therapeutics, Inc. | $36.65 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085802968 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.